News | March 03, 2022
Merck KGaA reports higher profits on strong volumes across its businesses
Company expects strong organic growth in sales, EBITDA in 2022
Company expects strong organic growth in sales, EBITDA in 2022
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida
More than 2,500 submissions are currently under review in the Food and Drug Administration's (FDA) cell and gene therapy pipeline
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
He has over 22 years of experience in pharmaceutical sales & business development
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Subscribe To Our Newsletter & Stay Updated
